However, the acetylcholinesterase inhibitor Rivastigmine can significantly increase the spectral power of α waves in AD patients [72], Clinically, AD patients receiving antipsychotic drug treatment have been found to develop drug resistance, with severe side effects occurring in the late stages of treatment, especially anxiety, agitation, or depression [73]. Here, ACHE is linked to Alzheimer disease.